More treatment options proposed for people with multiple myeloma and myelodysplastic syndrome

PHARMAC

23 April 2024 - PHARMAC is proposing to fund more treatments for people with a type of blood cancer, multiple myeloma, and some people with a blood cell disorder, myelodysplastic syndrome.

The funding would benefit over 800 New Zealanders and improve their quality of life.

Read PHARMAC Consultation

Michael Wonder

Posted by:

Michael Wonder